{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:41:41Z","timestamp":1774946501313,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T22:45:28Z","timestamp":1487285128000},"page":"5437-5443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Vaccine development for emerging virulent infectious diseases"],"prefix":"10.1016","volume":"35","author":[{"given":"Joel N.","family":"Maslow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"52","key":"10.1016\/j.vaccine.2017.02.015_b0005","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses","volume":"26","author":"Geisbert","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.02.015_b0010","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","author":"Henao-Restrepo","year":"2015","journal-title":"The Lancet"},{"issue":"6203","key":"10.1016\/j.vaccine.2017.02.015_b0020","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1126\/science.345.6203.1441","article-title":"Ebola vaccine: little and late","volume":"343","author":"Cohen","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.02.015_b0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East Respiratory Syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Int Med"},{"key":"10.1016\/j.vaccine.2017.02.015_b0030","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3346\/jkms.2015.30.12.1807","article-title":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-coronavirus from the central MERS-CoV designated hospital","volume":"30","author":"Cha","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2017.02.015_b0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","article-title":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia","volume":"29","author":"Saad","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0040","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3346\/jkms.2015.30.11.1701","article-title":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015","volume":"30","author":"M-d","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.015_b0045","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3201\/eid2006.140138","article-title":"Zika virus, French Polynesia, South Pacific, 2013","volume":"20","author":"Cao-Lormeau","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0050","doi-asserted-by":"crossref","first-page":"h6983","DOI":"10.1136\/bmj.h6983","article-title":"Zika virus spreads across Americas as concerns mount over birth defects","volume":"351","author":"Dyer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.02.015_b0055","unstructured":"European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus infection outbreak, French Polynesia, 14 February; 2014."},{"issue":"10","key":"10.1016\/j.vaccine.2017.02.015_b0060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3201\/eid2110.150847","article-title":"Zika virus outbreak, Bahia Brazil","volume":"21","author":"Campos","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0065","unstructured":"Pan Am Health Organization. Epidemiological alert. Zika virus infection. Pan Am Hlth Org [Internet]. 2015, 23 Jan 2016. Available from: <http:\/\/www.paho.org\/hq\/index.php?option=com_docman&task=doc_view&Itemid=270&gid=30075>."},{"key":"10.1016\/j.vaccine.2017.02.015_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.015_b0075","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","article-title":"Zika virus infection complicated by Guillain-Barre syndrome - case report, French Polynesia, December 2013","volume":"19","author":"Oehler","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2017.02.015_b0080","doi-asserted-by":"crossref","unstructured":"Brasil P, Pereira JP, Gabaglia CR, Damasceno L, Wakimoto M, Nogueira RMR, et al. Zika virus infection in pregnant women in Rio de Janeiro \u2013 Preliminary Report. N Engl J Med [Internet]; 2016 7 March 2016. http:\/\/dx.doi.org\/10.1056\/NEJMoa1602412.","DOI":"10.1056\/NEJMoa1602412"},{"key":"10.1016\/j.vaccine.2017.02.015_b0085","unstructured":"European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barre syndrome - 10 December; 2015."},{"key":"10.1016\/j.vaccine.2017.02.015_b0090","unstructured":"Pan Am Health Organization. Epidemiological alert. Neurological syndrome, congenital malformations, and Zika virus infection. Implications for public health in the Americas. 1 December 2015; 2015. Available from: <http:\/\/www.paho.org\/hq\/index.php?option=com_docman&task=doc_view&Itemid=270&gid=32405&lang=en>."},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.015_b0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.medmal.2014.04.008","article-title":"Current Zika virus epidemiology and recent epidemics","volume":"44","author":"Ioos","year":"2014","journal-title":"Med Mal Infect"},{"issue":"39","key":"10.1016\/j.vaccine.2017.02.015_b0100","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.39.20285-en","article-title":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction","volume":"17","author":"Corman","year":"2012","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.015_b0105","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem"},{"issue":"69655","key":"10.1016\/j.vaccine.2017.02.015_b0110","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.015_b0115","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1128\/JVI.00161-14","article-title":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection","volume":"88","author":"Barlan","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.015_b0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"10.1016\/j.vaccine.2017.02.015_b0125","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1073\/pnas.1323896111","article-title":"Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes","volume":"111","author":"Macdonald","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.015_b0130","doi-asserted-by":"crossref","first-page":"e0145561","DOI":"10.1371\/journal.pone.0145561","article-title":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome coronavirus","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.02.015_b0135","doi-asserted-by":"crossref","unstructured":"Cramer G, Durr PA, Klein R, Foord A, Yu M, Riddell S, et al. Experimental infection and response to rechallenge of alpacas with Middle East Respiratory Syndrome coronavirus. Emerg Infect Dis; 2016, vol. 22, 6 [Epub ePub ahead of print].","DOI":"10.3201\/eid2206.160007"},{"issue":"11","key":"10.1016\/j.vaccine.2017.02.015_b0140","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1128\/JVI.00661-15","article-title":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits","volume":"89","author":"Haagmans","year":"2015","journal-title":"J Virol"},{"issue":"301","key":"10.1016\/j.vaccine.2017.02.015_b0145","doi-asserted-by":"crossref","first-page":"e301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.02.015_b0150","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.015_b0155","doi-asserted-by":"crossref","first-page":"e1004250","DOI":"10.1371\/journal.ppat.1004250","article-title":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset","volume":"10","author":"Falzarano","year":"2014","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.015_b0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1306742","article-title":"Hospital outbreak of Middle East Respiratory Syndrome coronavirus","volume":"369","author":"Assiri","year":"2013","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2017.02.015_b0165","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMc1409847","article-title":"Evidence of camel-to-human transmission of MERS coronavirus","volume":"371","author":"Drosten","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.015_b0170","doi-asserted-by":"crossref","first-page":"28305","DOI":"10.3402\/iee.v5.28305","article-title":"High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014","volume":"5","author":"Farag","year":"2015","journal-title":"Infect Ecol Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.015_b0175","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","article-title":"Zika virus (II). Pathogenicity and physical properties","volume":"46","author":"Dick","year":"1952","journal-title":"Trans Roy Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.015_b0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus: (I). Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.02.015_b0185","first-page":"57","article-title":"Twelve isolations of Zika virus from Aedes (Stegomyia) africanus (Theobald) taken in and above a Ugandan forest","volume":"31","author":"Haddow","year":"1964","journal-title":"Bull Wld Hlth Org"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.015_b0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01249709","article-title":"Zika virus infection of the central nervous system of mice","volume":"35","author":"Bell","year":"1971","journal-title":"Arch Gesamte Virusforsch"},{"key":"10.1016\/j.vaccine.2017.02.015_b0195","doi-asserted-by":"crossref","unstructured":"Besnard M, Lastere S, Teissier A, Cao-Lormeau VM, Musso D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill; 2014, vol. 19, 13 [pii:-20751].","DOI":"10.2807\/1560-7917.ES2014.19.13.20751"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.015_b0200","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3201\/eid1705.101939","article-title":"Probable non-vector-borne transmission of Zika virus, Colorado, USA","volume":"17","author":"Foy","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.015_b0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3201\/eid2101.140894","article-title":"Detection of Zika virus in urine","volume":"21","author":"Gourinat","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2015.04.021","article-title":"Detection of Zika virus in saliva","volume":"68","author":"Musso","year":"2015","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.015_b0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3201\/eid2102.141363","article-title":"Potential sexual transmission of Zika virus","volume":"21","author":"Musso","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0220","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1601824","article-title":"Zika virus infection with prolonged maternal viremia and fetal brain abnormalities","author":"Driggers","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.015_b0225","unstructured":"Minist\u00e9rio da Sa\u00fade (Brazil). Microcefalia - Minist\u00e9rio da Sa\u00fade divulga boletim epidemiol\u00f3gico 2015, 30 Jan; 2016. Available from: <http:\/\/portalsaude.saude.gov.br\/index.php\/cidadao\/principal\/agencia-saude\/20805-ministerio-da-saude-divulga-boletim-epidemiologico.#sthash.MYQuW0Gh.dpuf>."},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.015_b0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/uog.15831","article-title":"Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?","volume":"47","author":"Oliveira Melo","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.015_b0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.015_b0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/cid\/civ951","article-title":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus Iinfection","volume":"62","author":"Corman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.015_b0245","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3201\/eid2112.151421","article-title":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea","volume":"21","author":"Park","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.015_b0250","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1473-3099(15)70090-3","article-title":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study","volume":"15","author":"M\u00fcller","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.015_b0255","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2017.02.015_b0260","doi-asserted-by":"crossref","DOI":"10.3201\/eid2210.160706","article-title":"Persistence of antibodies against Middle East Resporatory coronavirus","volume":"22","author":"Payne","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0265","doi-asserted-by":"crossref","unstructured":"Larocca RA, Abbink P, Peron JPS, de A Zanotto PM, Iampietro MJ, Badamchi-Zadeh A, et al. Vaccine protection against Zika virus from Brazil. Nature; 2016 http:\/\/dx.doi.org\/10.1038\/nature18952.","DOI":"10.1038\/nature18952"},{"key":"10.1016\/j.vaccine.2017.02.015_b0270","article-title":"Chimpanzee adenovirus vector Ebola Vaccine - Preliminary Report","author":"Ledgerwood","year":"2014","journal-title":"N Engl J Med"},{"issue":"10008","key":"10.1016\/j.vaccine.2017.02.015_b0275","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2017.02.015_b0280","unstructured":"Sardesai N, editor. Translating DNA vaccines and immunotherapies into advanced clinical studies. World Vaccine Congress; 2016 29\u201331 March 2016; Washington, D.C."},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.015_b0285","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/mt.2013.61","article-title":"Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola","volume":"21","author":"Shedlock","year":"2013","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2017.02.015_b0290","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/infdis\/jir054","article-title":"A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial","volume":"203","author":"Ledgerwood","year":"2011","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.015_b0295","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/523650","article-title":"A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial","volume":"196","author":"Martin","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.015_b0300","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/j.vaccine.2009.01.137","article-title":"Coimmunization with an optimized IL-15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII","volume":"27","author":"Ramanathan","year":"2009","journal-title":"Vaccine"},{"issue":"1 October","key":"10.1016\/j.vaccine.2017.02.015_b0305","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/323395","article-title":"Induction of potent Th1-Type Immune Responses from a Novel DNA Vaccine for West Nile Virus New York Isolate (WNV-NY1999)","volume":"184","author":"Yang","year":"2001","journal-title":"J Infect Dis"},{"issue":"6254","key":"10.1016\/j.vaccine.2017.02.015_b0310","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.349.6254.1272","article-title":"Ebola vaccines face daunting path to approval","volume":"349","author":"Cohen","year":"2015","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.vaccine.2017.02.015_b0315","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T12:44:46Z","timestamp":1749991486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":63,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17301962"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine development for emerging virulent infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}